Qiagen said this week that it has named Thomas Schweins as its vice president of corporate strategy.
The newly created position, said the company, involves developing, implementing, and monitoring Qiagen’s long-term strategy and market development activities. Schweins will also be responsible for defining the company’s licensing and acquisition strategy, while coordinating and monitoring the firm’s application portfolio.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
